Several of London’s top medical clinics located on Harley Street have begun adopting Premaz, a Cambridge-backed neuroprotective technology designed to support brain health. According to the company, the rollout marks a significant step toward wider clinical integration of its research-based product aimed at safeguarding cognitive function and addressing the growing need for preventive neurological care.
Premaz, developed through collaboration between neuroscientists and biotechnology experts, is described by the company as a pioneering approach to maintaining long-term brain health. It combines scientific insights from neurochemistry and molecular biology to help reduce the effects of oxidative stress and inflammation—two major factors associated with cognitive decline. The company said that by supporting cellular resilience, the product aims to help prevent early signs of neurological deterioration and improve overall brain function.
According to the company, its adoption by some of the most established medical centres on Harley Street demonstrates increasing interest in evidence-based wellness solutions that bridge the gap between clinical medicine and preventive health. The company claims that these clinics, known for their exclusive clientele and advanced medical offerings, will use Premaz as part of comprehensive wellness and longevity programs.
The company also stated that this development reflects the UK’s growing emphasis on integrative health solutions, combining neuroscience, biotechnology, and preventive medicine to enhance patient outcomes and support sustainable brain health across age groups.
The post Harley Street clinics adopt Cambridge-developed Premaz for brain health protection appeared first on Longevity.Technology – Latest News, Opinions, Analysis and Research.
